Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP9X inhibits Neoplasm Metastasis. 3 / 3

| 3

➶

reach

"The results indicated that FA-M (PTX) prevented pulmonary metastasis of H22, and the efficacy was stronger than pure PTX and simple PTX conjugated micelles."

24790440

➶

reach

"The depletion and pharmacological inhibition of USP9X by WP1130, an inhibitor of USP9X, downregulate endogenous Snail1 protein, inhibit cell migration, invasion, metastasis, and increase cellular sensitivity to cisplatin and paclitaxel both in vitro and in vivo, whereas the reconstitution of Snail1 in cells with USP9X depletion at least partially reverses these phenotypes."

35506169

➶

reach

"Furthermore, inhibition of USP9x in vivo suppressed obesity induced breast cancer metastasis."

28115363

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP9X inhibits Neoplasm Metastasis. 3 / 3

Our Sources:

Databases

Reading